Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-069559
Filing Date
2025-07-22
Accepted
2025-07-22 14:40:32
Documents
2
Period of Report
2025-07-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2521323-8_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2521323-8_3seq1.xml 3 1640
2 EXHIBIT 24 tm2521323d8_ex24.htm EX-24 20152
  Complete submission text file 0001104659-25-069559.txt   23483
Mailing Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103
Business Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103 6177728515
abrdn Life Sciences Investors (Issuer) CIK: 0000884121 (see all company filings)

EIN.: 043147016 | State of Incorp.: MA | Fiscal Year End: 0930
SIC: 0000

Mailing Address C/O ABERDEEN INVESTMENTS 1900 MARKET STREET, SUITE 200 PHILADELPHIA PA 19103
Business Address
Dietrick Joseph Francis (Reporting) CIK: 0002072478 (see all company filings)

Type: 3 | Act: 34 | File No.: 811-06565 | Film No.: 251139948